Mebufotenin - GH Research
Alternative Names: 5 Methoxy N N dimethyltryptamine - GH Research; 5 Methoxy N,N Dimethyltryptamine; 5-MeO-DMT; GH-001; GH-002; GH-003Latest Information Update: 25 Nov 2024
Price :
$50 *
At a glance
- Originator GH Research
- Class Antidepressants; Behavioural disorder therapies; Ethers; Mood stabilisers; Small molecules; Tryptamines
- Mechanism of Action Serotonin receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Bipolar disorders; Major depressive disorder; Postnatal depression
Most Recent Events
- 30 Sep 2024 GH Research completes enrolment in the phase II trial in Major depressive disorder (Treatment-resistant) in Czech Republic, Germany, Ireland, Netherlands, Poland and Spain (Inhalation)
- 01 Aug 2024 GH Research Limited initiates a phase I pharmacokinetic and safety trial in Healthy volunteers in United Kingdom (Inhalation) (NCT06511947)
- 01 Mar 2024 GH Research has patent protection for crystalline hydrobromide salt of mebufotenin in European Union